ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Overview Fund Activity
Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

37 hedge funds and large institutions have $765M invested in Orchard Therapeutics plc American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.11%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$321M
2
DM
Deerfield Management
New York
+$126M
3
RCM
RA Capital Management
Massachusetts
+$76.2M
4
CI
Cowen Inc
New York
+$46.1M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$30.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
DIM
26
DC Investments Management
Virginia
$674K +$674K +4,286 New
TD Asset Management
27
TD Asset Management
Ontario, Canada
$657K +$657K +4,175 New
Norges Bank
28
Norges Bank
Norway
$629K +$629K +4,000 New
Northern Trust
29
Northern Trust
Illinois
$579K +$579K +3,681 New
PPA
30
Parametric Portfolio Associates
Washington
$510K +$510K +3,242 New
CS
31
Credit Suisse
Switzerland
$179K +$179K +1,135 New
Morgan Stanley
32
Morgan Stanley
New York
$136K +$136K +863 New
Victory Capital Management
33
Victory Capital Management
Texas
$106K +$106K +672 New
KSCM
34
Kamunting Street Capital Management
Florida
$48K +$48K +305 New
UBS Group
35
UBS Group
Switzerland
$19K +$19K +124 New
CCA
36
Catalyst Capital Advisors
New York
$7K +$7K +46 New
Barclays
37
Barclays
United Kingdom
$2K +$2K +10 New
1
2